BioSpace News Archive

Job Trends

Pharma Execs are Attractive Candidates for Healthcare Leadership Roles

Healthcare companies are now looking at pharma executives for leadership roles as the landscape of healthcare is dramatically changing.

March 23, 2018
·
2 min read
·
Alex Keown
Deals

GSK Walks Away From Acquiring Pfizer Consumer Goods Unit

GlaxoSmithKline has decided not to make a play for Pfizer’s consumer health business. The decision came one day after another potential suitor walked away from a potential deal.

March 23, 2018
·
2 min read
·
Alex Keown
Drug Development

Novartis Published Multiple Sclerosis Trial Data With Plans to File for FDA Approval

Novartis released full results from its Phase III EXPAND trial of siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS), which it published in the journal The Lancet.

March 23, 2018
·
2 min read
·
Mark Terry
German Biotech MorphoSys Seeks Nasdaq Listing

MorphoSys, a Germany-based biopharmaceutical company, is aiming for a listing on the Nasdaq exchange hoping to secure approximately $150 million.

March 23, 2018
·
2 min read
·
Alex Keown
Deals

Akebia Announces $85M Public Offering

Akebia Therapeutics, a kidney disease company, announced plans to offer and sell about $85 million of its common stock in an underwritten public offering.

March 23, 2018
·
2 min read
·
Mark Terry
Job Trends

HER Foundation Helps UCLA, USC and 23&Me Link Debilitating Pregnancy Illness to Two Genes

A breakthrough for women suffering from the severe pregnancy illness Hyperemesis Gravidarum.

March 23, 2018
·
3 min read
Drug Development

Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers

The study is a regulatory post marketing commitment for CHANTIX/CHAMPIX in the U.S. and EU for adolescents 12-16 years and 12-17 years of age, respectively.

March 23, 2018
·
7 min read
Genetown

Akebia Therapeutics Announces Pricing of Public Offering of Common Stock

Akebia announced the pricing of an underwritten public offering of 8,500,000 shares of common stock at a price to the public of $10.50 per share.

March 23, 2018
·
3 min read
Pharm Country

Medical and Legal Cannabis Markets are Projected to Increase in Value

Data published by Energias Market Research estimates that the global medical cannabis market is expected to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion in 2024, at a CAGR of 19.1% from 2018 to 2024.

March 23, 2018
·
10 min read
Biotech Beach

Radio Program ‘In Your Right Mind’ will Explore Behavioral Addictions in a New Broadcast on 790 AM KABC

“In Your Right Mind,” is set to air an informative show “Process Addictions,” this Sunday, March 25, at 5 p.m. Pacific Standard Time on Talk Radio 790 AM KABC Los Angeles.

March 23, 2018
·
3 min read